Medical News

RSS

Study reports self-disinfecting polymer surfaces that can inactivate SARS-CoV-2

Surfaces with anionic block copolymers can inactivate different viruses within minutes by making the polymer-microbe interface very acidic. Such surfaces can continuously disinfect surfaces without the need for reapplication of disinfectant.

14 Jun 2021

Study suggests COVID-19 in children is milder than the flu

Researchers retrospectively analyzed the medical records of children in Turkey hospitalized because of coronavirus disease 2019 (COVID-19) or influenza and found COVID-19 to be milder than influenza in this group.

14 Jun 2021

Enterprise Therapeutics doses first subjects in Phase I trial for novel cystic fibrosis therapy ETD001

Enterprise Therapeutics Ltd today announced it has successfully dosed the first subjects in a Phase 1 trial for its novel inhaled cystic fibrosis therapy, ETD001.

14 Jun 2021

British Liver Trust calls for action to address rising obesity rates that fuel liver disease crisis

The British Liver Trust is calling for greater awareness of a silent yet serious form of fatty liver disease, non-alcohol related steatohepatitis (NASH), as one million adults were reported to have been admitted to hospital with obesity-related conditions in 2020.

14 Jun 2021

New poll finds low public awareness of how to get enough vitamin D year-round

Despite vitamin D being essential for healthy bones, only half of people (51%) realize that it is important for bone health and 43% have never even considered what they need to do to look after their bones, according to a recent poll of 2,000 UK adults by YouGov and commissioned by the Royal Osteoporosis Society (ROS).

14 Jun 2021

Forkhead box O's potential therapeutic use in the treatment of COVID-19

In a recent study, Indian researchers from the Department of Biochemistry, University of Delhi, reviewed a possible vital coalition of FoxOs - the Forkhead Box O subfamily of protein transcription factors, with SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), the etiological agent of COVID-19 (coronavirus disease).

13 Jun 2021

What makes the elderly more susceptible to SARS-CoV-2 infection?

Why is severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19 (coronavirus disease 2019), biased towards infecting the aged population? A recently published study by Italian scientists linked aging, DNA damage, telomere shortening, and increased levels of angiotensin-converting enzyme 2 (ACE2) to this relationship.

13 Jun 2021

Super-resolution imaging technique could enable early detection of neurological disorders

A new imaging technique has the potential to detect neurological disorders--such as Alzheimer's disease--at their earliest stages, enabling physicians to diagnose and treat patients more quickly.

13 Jun 2021

Joint ICMRA and WHO statement explains how COVID-19 vaccines are regulated for safety, effectiveness

Healthcare professionals and public health authorities have a central role in discussing vaccination against COVID-19 with their patients.

13 Jun 2021

Sudden cardiac arrest can happen to anyone, at anytime

"It was a chilling sight for anyone who saw it," said Professor Stephan Achenbach, president of the European Society of Cardiology, the world's largest organization of heart doctors.

13 Jun 2021

Teachers and school staff should be prioritised for COVID vaccines

In a communication paper recently published in the Journal of Paediatrics and Child Health by Koirala et al. (June 8th, 2021), it is argued that Australian schools should remain open, with proper testing, tracing, and quarantine protocols in place.

13 Jun 2021

Philippines poorly prepared to deal with COVID-19, report says

In a recent study published in the WHO WPSAR journal, researchers described the challenges and early response of the Philippines to COVID-19.

13 Jun 2021

Role of traditional medicine against SARS-CoV-2

A group of researchers at Kannur University reviewed selected papers and in silico work on potential drug leads that could be used to manage COVID-19.

13 Jun 2021

Humoral innate pattern recognition molecules against SARS-CoV-2

In a paper recently uploaded to the preprint server medRxiv by Garlanda et al. (June 8th, 2021), humoral pattern recognition molecules are explored for affinity towards SARS-CoV-2, contributing to unraveling the role of these molecules in COVID-19 disease progression.

13 Jun 2021

Long-range airborne transmission of SARS-CoV-2

In an early release copy of a short commentary paper recently published in the Canadian Medical Association Journal by Addleman et al. (June 8th, 2021), the impact of, and possible solutions to, the short- and long-range airborne transmission of SARS-CoV-2 are explored.

13 Jun 2021

An analysis links COVID-19 to brain microvascular injury and inflammation

The ongoing COVID-19 pandemic is caused by the severe acute respiratory syndrome-2 (SARS-CoV-2), an RNA virus that belongs to the family Coronaviridae. According to research, coronavirus disease 2019 (COVID-19) patients often suffer from neurological disorders like strokes, lost taste or smell, memory loss, confusion, and delirium.

13 Jun 2021

Study reveals maternal and neonatal benefits of Pfizer COVID-19 mRNA vaccine

A new commentary, published as an ‘In-Press Preview’ in the Journal of Clinical Investigation, addresses the salient issue of vaccination against the coronavirus disease (COVID-19) in pregnancy and potential antibody transfer to the fetus – and provides the evidence in support of messenger RNA (mRNA) vaccine safety and efficacy for both maternal and child health.

13 Jun 2021

Study shows poor antibody response in naive elderly of nursing homes after mRNA vaccination

A new study describes inadequate antibody responses to the Pfizer/BioNTech vaccine against coronavirus disease 2019 (COVID-19) in elderly residents of a care home with no prior history of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), compared to those with such a history. This adds to the current understanding of vaccine efficacy against infection.

13 Jun 2021

PET radiotracer can noninvasively identify and monitor pulmonary fibrosis

Positron emission tomography (PET) using a 68Ga-labeled fibroblast activation protein inhibitor (FAPI) can noninvasively identify and monitor pulmonary fibrosis, according to research presented at the Society of Nuclear Medicine and Molecular Imaging 2021 Annual Meeting.

13 Jun 2021

Advanced AI technique can accurately predict major adverse cardiac events

An advanced artificial intelligence technique known as deep learning can predict major adverse cardiac events more accurately than current standard imaging protocols, according to research presented at the Society of Nuclear Medicine and Molecular Imaging 2021 Annual Meeting.

13 Jun 2021